Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Lepu Biopharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$2.9

2024-07-19

Market Capitalization

$5 B

2024-07-19

Revenue

¥225.4 M

FY, 2023

CreditSafe Score

?
Score changed on Jul 20, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2019FY, 2020FY, 2021FY, 2022FY, 2023
Revenue15.6M225.4M
Cost of goods sold2.0M28.3M
Gross profit3.5M2.9M5.6M24.7M204.2M
Gross profit margin, %158.5%90.6%
Operating expense total372.4M366.0M853.3M570.1M485.5M
Depreciation and amortization49.3M84.1M95.2M95.4M102.6M
EBITDA(377.5M)(375.2M)(865.4M)(577.7M)(308.6M)
EBITDA margin, %-3709.9%-136.9%
EBIT(426.7M)(459.3M)(961.6M)(673.9M)(197.5M)
EBIT margin, %-4327.9%-87.6%
Interest income396.0K5.3M4.1M45.9M8.3M
Interest expense52.6M86.3M3.3M8.6M16.0M
Pre tax profit(515.5M)(613.4M)(1.0B)(699.4M)(30.3M)
Net Income(515.5M)(613.4M)(1.0B)(699.4M)(30.3M)

Footer menu